Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 26 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  2. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  3. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  4. US 10051880

    Hydroxybutyrate ester and medical use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  5. US 10046012

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  6. US 10047122

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  7. US 10047147

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  8. US 10047148

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  9. US 10047401

    Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  10. US 10035848

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  11. US 10036020

    Compositions and methods for inhibiting JC virus (JCV)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  12. US 10035844

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  13. US 10035845

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  14. US 10035833

    Vascular endothelial growth factor antagonists and methods of making

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  15. US 10035832

    HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  16. US 10017543

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  17. US 10017516

    BMP inhibitors and methods of use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  18. US 10017762

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  19. US 10016432

    Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  20. US 10001483

    Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  21. US 10000813

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  22. US 9987330

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  23. US 9982025

    Monomeric griffithsin tandemers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2018 · Expires May 24, 2038

    granted

  24. US 9974868

    Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.